Microbix Biosystems (OTC:MBXBF) Stock, Quote.Headers.trade-ideas

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.

News

Intraday Update

Markets

Movers

Trading Ideas

ABEV

ABIO

ABMD

ABVC

ACCYY

ACHV

ACIW

ACOR

ACRFF

ACRX

ACSAY

ACST

ADHC

ADMA

ADMP

AEGOF

AFLYY

AFRAF

AGCO

AGEEF

AHKSY

AHOTF

AIBGY

AIPUY

AKRX

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALLY

ALMFF

ALOT

ALSN

ALTM

ALXN

AMADY

AMCX

AMKBF

AMKBY

AMNP

AMPH

AMRH

AMRQQ

AMTX

ANAT

ANCN

ANGO

ANIP

ANZLY

APEX

APHA

APLE

APTS

AQARF

ARCB

ARCH

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

MICROBIX BIOSYSTEMS INC by Microbix Biosystems Inc.

Microbix Biosystems Inc

Hawkins, Inc. declares $0.16 dividend

Keurig Dr Pepper Inc. declares $0.215 dividend

Ingredion Incorporated declares $0.78 dividend

Yum! Brands, Inc. declares $0.67 dividend

Microbix Biosystems GAAP EPS of $2.45, revenue of $152M

Microbix Biosystems Inc. (MBXBF) Q2 2024 Earnings Call Transcript

Microbix Biosystems initiates normal course issuer bid

Microbix Biosystems GAAP EPS of $0.003, revenue of $6.29M

Microbix Biosystems GAAP EPS of C$0.003, revenue of C$6.29M

Microbix Biosystems Inc. (MBXBF) Q4 2024 Earnings Call Transcript

CMPGF

CRZBF

MBXBF

Press Releases

Microbix Schedules Release of Results for Q3 Fiscal 2024

Earnings

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Microbix Presenting at Muskoka Capital Conference

Health Care

General

Microbix Achieves Essential EU Regulatory Accreditations

Microbix Presents Novel HSV Test Control at EMMD

KOL Collaborators Present Microbix HPV Test-Control Results

Microbix Announces Initiation of Normal Course Issuer Bid

Microbix Assisting EMQN with Novel Genetic-Test EQA Program

Microbix Schedules Release of Results for Q4 Fiscal 2024

Microbix Reports Record Product Sales for Q4 and Fiscal 2024

TSX:MBX

Microbix Biosystems

Comments

Microbix Biosystems

Microbix Biosystems (MBXBF) Forecast

Microbix Biosystems (OTC:MBXBF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga